Development of alpha-tocopherol acetate nanoparticles: influence of preparative processes

Drug Dev Ind Pharm. 2009 Feb;35(2):216-23. doi: 10.1080/03639040802248798.

Abstract

We studied different methods of preparing alpha-tocopherol acetate (ATA) nanoparticles, which are to be used in targeting the lungs as aerosols in order to prevent cigarette smoke toxicity. Poly-(lactide) nanoparticles were prepared using nanoprecipitation and solvent evaporation techniques, which produced, respectively, too small and too large nanoparticles to be aerosolized. The emulsification-diffusion method produced 2 months stable nanoparticles with a size between (500-700 nm). Increasing ATA concentration (1-7 mg/mL) induced a decrease in the association rate (97-93%) and in the adsorbed ATA rate (7-4.5%), which was associated with variations of Zeta potentials (-27.5 to -24.3 mV) and decrease in polymeric wall thickness and density.

MeSH terms

  • Aerosols / chemistry
  • Antioxidants / administration & dosage*
  • Antioxidants / chemistry*
  • Antioxidants / therapeutic use
  • Diffusion
  • Drug Compounding / methods
  • Drug Delivery Systems*
  • Drug Stability
  • Emulsions
  • Lung / metabolism
  • Nanoparticles*
  • Nanotechnology / methods
  • Nicotiana / toxicity
  • Particle Size
  • Tobacco Smoke Pollution / prevention & control
  • alpha-Tocopherol / administration & dosage*
  • alpha-Tocopherol / chemistry*
  • alpha-Tocopherol / therapeutic use

Substances

  • Aerosols
  • Antioxidants
  • Emulsions
  • Tobacco Smoke Pollution
  • alpha-Tocopherol